Liewei Wang, M.D., Ph.D., receives second year of funding for Developmental Research Program, Mayo Clinic Cancer Center Women’s Cancer Program and Breast Cancer and Ovarian Cancer SPORES

Liewei Wang, M.D., Ph.D. (MPET ’03, PHAR ’03), Department of Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic in Rochester, received a second year of funding with a for a 2018-2019 Developmental Research Program award, along with colleague Saravut (John) Weroha, M.D., Ph.D. (I ’10, CI ’11, HEMO ’13), for the project “Repurposing of Decitabine in Breast and Ovarian Cancer” from the Mayo Clinic Cancer Center Women’s Cancer Program and Breast Cancer and Ovarian Cancer SPORES.